Piperacillin

Piperacillin

SCHEMBL3225030

CCN1CCN(C(=O)NC(C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O.O

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Piperacillin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.76
▸ KMT2A Q03164 2/20 0.76
▸ CCKBR P32239 1/20 0.76
▸ LMNA P02545 3/20 0.66
▸ KDM4E B2RXH2 3/20 0.60
▸ RECQL P46063 3/20 0.60
▸ TDP1 Q9NUW8 2/20 0.60
▸ TSHR P16473 1/20 0.60
▸ POLB P06746 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ TEK Q02763 1/20 0.58
▸ SLC15A2 Q16348 1/20 0.58
▸ CA1 P00915 8/20 0.57
▸ CA2 P00918 8/20 0.57
▸ PTGS1 P23219 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperacillin SCHEMBL261048 1.00 MEN1 (0.76) MEN1KMT2ACCKBRLMNAKDM4E
Piperacillin SCHEMBL3233001 0.99 MEN1 (0.77) MEN1KMT2ACCKBRLMNAKDM4E
Piperacillin SCHEMBL14506140 0.99 MEN1 (0.77) MEN1KMT2ACCKBRLMNAKDM4E
Piperacillin SCHEMBL13788684 0.99 MEN1 (0.77) MEN1KMT2ACCKBRLMNAKDM4E
Piperacillin SCHEMBL33894 0.99 MEN1 (0.77) MEN1KMT2ACCKBRLMNAKDM4E
Piperacillin SCHEMBL24437361 0.99 MEN1 (0.77) MEN1KMT2ACCKBRLMNAKDM4E
Piperacillin SCHEMBL4486297 0.99 MEN1 (0.77) MEN1KMT2ACCKBRLMNAKDM4E
Piperacillin SCHEMBL13788683 0.99 MEN1 (0.77) MEN1KMT2ACCKBRLMNAKDM4E
Piperacillin SCHEMBL11908507 0.99 MEN1 (0.77) MEN1KMT2ACCKBRLMNAKDM4E
Piperacillin SCHEMBL10477435 0.99 MEN1 (0.77) MEN1KMT2ACCKBRLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100063273-A1 NOVEL CRYSTAL OF PIPERACILLIN SODIUM TOYAMA CHEMICAL CO., LTD (JP) 2010-03-11 — — US claimed
EP-2128162-A1 NOVEL CRYSTAL OF PIPERACILLIN SODIUM Toyama Chemical Co., Ltd. (JP) 2009-12-02 — — EP claimed
CN-101611040-A The novel crystal of piperacillin sodium TOYAMA CHEMICAL CO LTD (JP) 2009-12-23 — — CN disclosed
EP-0294789-B1 Process for preparing 6-/D(-)-Alpha-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-phenylacetamido/pennicillanic acid KRKA TOVARNA ZDRAVIL (YU) 1994-10-12 — — EP disclosed
EP-0294789-A1 Process for preparing 6-/D(-)-Alpha-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-phenylacetamido/pennicillanic acid KRKA, tovarna zdravil, n.sol.o (YU) 1988-12-14 — — EP disclosed
Send feedback